Concepedia

Faika Mseeh

FM

Statistics

Publications

24

Citations

2.9K

H-Index

20

Active since

2002

Affiliations

Lexicon Pharmaceuticals (United States)(Current)

The University of Texas MD Anderson Cancer Center

Northwestern University

Igenbio (United States)

Howard Hughes Medical Institute

Faika Mseeh is an author at Lexicon Pharmaceuticals (United States) specializing in pharmacology, medicine, and diabetes mellitus.

Publications per year

2002–2021

24

Publications

24

Experimental Determination and System Level Analysis of Essential Genes in <i>Escherichia coli</i> MG1655

Svetlana Gerdes, Michael D. Scholle, John W. Campbell et al. · Journal of Bacteriology · 2003 · 735 citations · Full text

, , +14

Lrp5 functions in bone to regulate bone mass

Yajun Cui, Paul Niziolek, Bryan T. MacDonald et al. · Nature Medicine · 2011 · 452 citations · Full text

, , +12

From Genetic Footprinting to Antimicrobial Drug Targets: Examples in Cofactor Biosynthetic Pathways

Svetlana Gerdes, Michael D. Scholle, Mark D’Souza et al. · Journal of Bacteriology · 2002 · 280 citations · Full text

, , +15

LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial

Brian Zambrowicz, J Freiman, Phil Brown et al. · Clinical Pharmacology & Therapeutics · 2012 · 239 citations · Full text

, , +17

LX4211 Increases Serum Glucagon-Like Peptide 1 and Peptide YY Levels by Reducing Sodium/Glucose Cotransporter 1 (SGLT1)–Mediated Absorption of Intestinal Glucose

David R. Powell, Melinda Smith, Jennifer Greer et al. · Journal of Pharmacology and Experimental Therapeutics · 2013 · 183 citations

, , +15

1–5 of 24